[The effect of birth weight and early growth on body fat composition and insulin sensitivity]

Mu-Xue Yu1, Xiao-Shan Qiu, Su-E Feng

  • 1Department of Pediatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Insights

Children with lower birth weight experiencing rapid early growth, and those with higher birth weight, showed increased body fat composition. These groups are at higher risk for insulin resistance in childhood.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Growth and Development

Context:

  • Birth weight and early postnatal growth are critical determinants of childhood health.
  • Understanding their impact on body composition and metabolic profiles is essential for early intervention.

Purpose:

  • To investigate the relationship between birth weight, early growth patterns, and body fat composition.
  • To assess the association of these factors with insulin sensitivity in children aged 6-7 years.

Summary:

  • This study analyzed data from 258 children, categorizing them by birth weight and weight change (SDS) from 0-36 months.
  • Results indicate that lower birth weight with significant weight gain, and higher birth weight, are linked to increased BMI, body fat percentage, and waist-to-height ratio.
  • These groups also exhibited higher insulin resistance (HOMA-IR).

Impact:

  • Identifies specific early life growth trajectories and birth weight categories associated with increased adiposity and insulin resistance.
  • Highlights potential targets for preventative strategies to mitigate metabolic risks in childhood.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...